Xcyte seeking alternatives

Xcyte (XCYT) retained SG Cowen to help it seek strategic alternatives, including mergers and acquisitions. The company also promoted Robert Kirkman to acting president and CEO, from VP and CBO. He replaces Ron Berenson, who becomes director of Xcellerate R&D and will remain on XCYT's board. ...